PHS
DVAX

PFM Health Sciences’s Dynavax Technologies DVAX Stock Holding History

PFM Health Sciences’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-521,800
Closed -$10M – 79
2021
Q3 		$10M Buy
+521,800
New +$6.93M 0.29% 62
2021
Q2 		– Sell
-500,000
Closed -$4.92M – 87
2021
Q1 		$4.92M Buy
+500,000
New +$4.12M 0.15% 80

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PFM Health Sciences's DVAX Position: Q3 2023 in Review

PFM Health Sciences sold out of Dynavax Technologies (DVAX) in Q3 2023, closing a stake of 2,704,917 shares — an estimated $34.9M sold.

PFM Health Sciences first reported a position in DVAX in Q2 2020 and held it in 13 quarters. The position peaked at $63.1M in Q3 2021. 225 funds tracked by Wall St. Rank hold DVAX as of Q3 2023.

  • PFM Health Sciences reported no remaining Dynavax Technologies position as of Q3 2023 after selling out during the quarter.
  • PFM Health Sciences sold 2,704,917 Dynavax Technologies shares in Q3 2023, an estimated $34.9M.
  • PFM Health Sciences first reported a position in Dynavax Technologies in Q2 2020 and held it in 13 quarters.
  • PFM Health Sciences's Dynavax Technologies position peaked at $63.1M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2023.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.